MOG and myeloid sarcoma: In addition, the time interval between the initial clinical episode and declining MOG-Ab levels can differ markedly between children with MOG-Ab-positive ADEM [48], making it difficult to predict the immediate future course once the persistence of high MOG-Ab titers is strongly associated with a recurrent non-MS disease course [48].